SUBSCRIBE
SUBSCRIBE
News   Deals

SGX Pharmaceuticals, Inc. Sets 4-Million-Share IPO At $11-$13

January 4, 2006 | 
1 min read
WASHINGTON, Jan 4 (Reuters) - SGX Pharmaceuticals Inc., a biotechnology company, on Wednesday set its planned initial public offering at 4 million shares at an estimated price of $11 to $13 each.
IPO
MORE ON THIS TOPIC
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Gene editing
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
December 1, 2025
 · 
1 min read
 · 
Tristan Manalac
Business partners run with big arrow in different directions. Conflict, choice right way business development. Team leadership competition. Quarrel, battle and problems. Flat vector illustration
Mergers & acquisitions
Avidity Played Hardball To Land Favorable Terms in $12B Novartis Deal
November 25, 2025
 · 
3 min read
 · 
Annalee Armstrong
Hand turns dice and changes the expression 'know the rules'. to 'follow the rules'.
Drug Development
CRO Boom in APAC Region, With China at the Forefront
November 19, 2025
 · 
5 min read
 · 
Jennifer Smith-Parker
Relay race. Concept of teamwork. working together of business. Vector illustration
Mergers & acquisitions
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
November 19, 2025
 · 
9 min read
 · 
Tristan Manalac